Nicolas Folschweiller

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Cervical Cancer Screening

Randomized Controlled Trial

Top Venues

Human vaccines & immunotherapeutics

The Journal of infectious diseases

Journal of viral hepatitis

GSK Pharmaceutical

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GSK Pharmaceutical Feb 16 2010

Belgium

Clinical Research and Development Lead

Publications

Joseph E Tota, Frank Struyf, Allan Hildesheim, Paula Gonzalez, Martin Ryser, Rolando Herrero, John Schussler, Naveen Karkada, Ana Cecilia Rodriguez, Nicolas Folschweiller, Carolina Porras, Mark Schiffman, John T Schiller, Wim Quint, Aimée R Kreimer, Matti Lehtinen, Cosette M Wheeler, Joshua N Sampson
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study. The Journal of infectious diseases 223 (9) (2022)
Pierre Van Damme, Marc Dionne, Geert Leroux-Roels, Olivier Van Der Meeren, Emmanuel Di Paolo, Bruno Salaun, Pemmaraju Surya Kiran, Nicolas Folschweiller
Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. Journal of viral hepatitis 26 (9) (2019)
Tino F Schwarz, Li-Min Huang, Alejandra Valencia, Falko Panzer, Cheng-Hsun Chiu, Annabelle Decreux, Sylviane Poncelet, Naveen Karkada, Nicolas Folschweiller, Lan Lin, Gary Dubin, Frank Struyf
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Human vaccines & immunotherapeutics 15 (7-8) (2019)